California Seeks to Stop Pay-to-delay Generic Drug Agreements

Three of the top pharmaceutical companies have entered agreements to pay the state of California nearly $70 million to settle allegations that they “delayed drugs to keep prices high” according to California Attorney General Xavier Becerra.  Most of the funds will come from Teva Pharmaceuticals ($69 million) for paying to delay a generic for Provigil,

Opioid Distributors and AGs Try to Negotiate Settlement in Billions

Cardinal Health, McKesson, and AmerisourceBergen have proposed paying $10 billion to settle all claims that they contributed to the opioid crisis.  All three opioid distributors have been hit hard with claims that they did not do enough to flag and discontinue shipping large, suspicious orders of addictive drugs.  The companies made the verbal proposal with